These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31421255)

  • 1. A novel in vivo predictive dissolution testing coupled with a modeling and simulation for hydrogel matrix monolithic extended release oral dosage forms.
    Kambayashi A; Dressman JB
    Eur J Pharm Sci; 2019 Oct; 138():105044. PubMed ID: 31421255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.
    Walsh PL; Bothe JR; Bhardwaj S; Hu M; Nofsinger R; Xia B; Persak S; Pennington J; Bak A
    Drug Dev Ind Pharm; 2016; 42(5):836-44. PubMed ID: 26339722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the Oral Pharmacokinetics and Food Effects of Gabapentin Enacarbil Extended-Release Tablets Using Biorelevant Dissolution Tests.
    Yamaguchi Ikeuchi S; Kambayashi A; Kojima H; Oku N; Asai T
    Biol Pharm Bull; 2018; 41(11):1708-1715. PubMed ID: 30381671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Biopredictive In Vitro Comparison of Oral Locally Acting Mesalazine Formulations by a Novel Dissolution Model for Assessing Intraluminal Drug Release in Individual Subjects.
    Karkossa F; Klein S
    J Pharm Sci; 2018 Jun; 107(6):1680-1689. PubMed ID: 29499277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
    Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
    J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
    Tajiri S; Kanamaru T; Kamada M; Konno T; Nakagami H
    Int J Pharm; 2010 Jan; 383(1-2):99-105. PubMed ID: 19747964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms.
    Takieddin M; Fassihi R
    AAPS PharmSciTech; 2015 Apr; 16(2):278-83. PubMed ID: 25273030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets.
    Beloica S; Cvijić S; Bogataj M; Parojčić J
    Eur J Pharm Sci; 2015 Jul; 75():151-9. PubMed ID: 25861718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In Vitro Dissolution Method for Testing Extended-Release Tablets Under Mechanical Compression and Sample Friction.
    Gao Z; Cao LNY; Liu X; Tian L; Rodriguez JD
    J Pharm Sci; 2022 Jun; 111(6):1652-1658. PubMed ID: 34742730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
    Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
    Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
    Mamani PL; Ruiz-Caro R; Veiga MD
    Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the risk of alcohol-induced dose dumping from sustained-release oral dosage forms: in vitro-in silico approach.
    Cvijić S; Aleksić I; Ibrić S; Parojčić J
    Pharm Dev Technol; 2018 Nov; 23(9):921-932. PubMed ID: 29043886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - case study of multimodal characterization of quetiapine fumarate tablets.
    Kulinowski P; Woyna-Orlewicz K; Rappen GM; Haznar-Garbacz D; Węglarz WP; Dorożyński PP
    Int J Pharm; 2015 Apr; 484(1-2):235-45. PubMed ID: 25701626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.